PEDIATRICS Vol. 89 No. 6 June 1992, pp. 1095-1098
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DARMSTADT, G. L.
Right arrow Articles by SWEREN, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DARMSTADT, G. L.
Right arrow Articles by SWEREN, R. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Eosinophilic Pustular Folliculitis

GARY L. DARMSTADT MD1, WALTER W. TUNNESSEN JR MD1, and RONALD J. SWEREN MD1

1 Division of Pediatric Dermatology, Depts of Pediatrics and Dermatology, The Johns Hopkins University School of Medicine, Baltimore, MD

Eosinophilic pustular folliculitis is a cutaneous disorder that consists of recurrent crops of pruritic, sterile, papulopustules in a follicular distribution. In pediatric patients, EPF presents primarily in the scalp and is confused with several other more common dermatoses in children. The diagnosis of EPF rests on its inclusion in the differential diagnosis of papulo-pustular disorders, the recognition of the clinical presentation, and the presence of an eosinophilic infiltrate on biopsy. Treatment with midpotency topical coticosteroids has thus far met with modest success.

This is the first report on EPF in the pediatric literature. As pediatricians become more aware of EPF as a distinct clinical entity and as our clinical experience and insight into the pathogenesis of EPF grows, perhaps more effective treatment modalities will be devised.

Submitted on February 27, 1991
Accepted on June 17, 1991


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Arch DermatolHome page
C. C. Otley, M. R. Avram, and R. A. Johnson
Isotretinoin Treatment of Human Immunodeficiency Virus-Associated Eosinophilic Folliculitis: Results of an Open, Pilot Trial
Arch Dermatol, September 1, 1995; 131(9): 1047 - 1050.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
A. M. Duarte, J. Kramer, J. W. Yusk, A. Paller, and L. A. Schachner
Eosinophilic Pustular Folliculitis in Infancy and Childhood
Arch Pediatr Adolesc Med, February 1, 1993; 147(2): 197 - 200.
[Abstract] [PDF]